Vivos (RDGL) Accumulated Expenses (2010 - 2021)

Vivos (RDGL) reported Accumulated Expenses of $118869.0 for Q3 2021, up 25.68% on a YoY basis from $94577.0 in Q3 2020, and up 5.43% sequentially from $112745.0 in Q2 2021.

Vivos (RDGL) Accumulated Expenses (2010 - 2021) Analysis & Trends

Vivos (RDGL) has 12 years of Accumulated Expenses data on file, last reported at $118869.0 in Q3 2021.

  • For the quarter ending Q3 2021, Accumulated Expenses rose 25.68% year-over-year to $118869.0; the trailing twelve-month figure through Sep 2021 stood at $118869.0 (up 25.68% YoY), and the FY2020 full-year result was $100954.0, up 0.95% from the prior year.
  • Accumulated Expenses rose to $118869.0 in Q3 2021, from $112745.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $347069.0 in Q4 2017 to a low of $5953.0 in Q1 2018.
  • A 5-year average of $98946.5 and a median of $80000.0 in 2019 frame the typical range for Accumulated Expenses.
  • Across the five-year window, Accumulated Expenses tumbled 96.7% in 2018 and jumped 773.29% in 2019, its largest moves.
  • Tracing RDGL's Accumulated Expenses over 5 years: stood at $347069.0 in 2017, then plunged by 96.7% to $11451.0 in 2018, then surged by 773.29% to $100000.0 in 2019, then grew by 0.95% to $100954.0 in 2020, then advanced by 17.75% to $118869.0 in 2021.
  • Business Quant data shows RDGL's Accumulated Expenses at $118869.0 in Q3 2021, $112745.0 in Q2 2021, and $106690.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Vivos 27.16 Mn 25.60 Mn -3,105.00

Historic Data

Download Data
DateValue
Sep 30, 2021 118,869.00
Jun 30, 2021 112,745.00
Mar 31, 2021 106,690.00
Dec 31, 2020 100,954.00
Sep 30, 2020 94,577.00
Jun 30, 2020 27,536.00
Mar 31, 2020 23,430.00
Dec 31, 2019 100,000.00
Sep 30, 2019 80,000.00
Jun 30, 2019 69,209.00
Mar 31, 2019 20,000.00
Dec 31, 2018 11,451.00
Sep 30, 2018 290,336.00
Jun 30, 2018 216,436.00
Mar 31, 2018 5,953.00
Dec 31, 2017 347,069.00
Sep 30, 2017 51,576.00
Jun 30, 2017 51,576.00
Mar 31, 2017 51,576.00
Dec 31, 2016 86,752.00